Yohta Shimada

3.5k total citations
51 papers, 875 citations indexed

About

Yohta Shimada is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Yohta Shimada has authored 51 papers receiving a total of 875 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Physiology, 21 papers in Molecular Biology and 16 papers in Epidemiology. Recurrent topics in Yohta Shimada's work include Lysosomal Storage Disorders Research (34 papers), Trypanosoma species research and implications (10 papers) and Neurogenetic and Muscular Disorders Research (7 papers). Yohta Shimada is often cited by papers focused on Lysosomal Storage Disorders Research (34 papers), Trypanosoma species research and implications (10 papers) and Neurogenetic and Muscular Disorders Research (7 papers). Yohta Shimada collaborates with scholars based in Japan, United States and Taiwan. Yohta Shimada's co-authors include Toya Ohashi, Hiroyuki Ida, Hiroshi Kobayashi, Yoshikatsu Eto, Takashi Higuchi, Takahiro Fukuda, Yohei Sato, Takashi Higuchi, Hirotaka James Okano and Hiromi Shimizu and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Yohta Shimada

49 papers receiving 859 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yohta Shimada Japan	19	462	365	196	129	113	51	875
Patrycja M. Dubielecka United States	20	368 0.8×	652 1.8×	102 0.5×	125 1.0×	33 0.3×	68	1.1k
Martine Bot Netherlands	16	214 0.5×	534 1.5×	109 0.6×	103 0.8×	174 1.5×	23	1.1k
Mohga El‐Abbadi United States	14	342 0.7×	439 1.2×	45 0.2×	55 0.4×	107 0.9×	15	1.1k
Jacqueline M. Kraveka United States	18	199 0.4×	949 2.6×	132 0.7×	204 1.6×	12 0.1×	36	1.5k
Martina Gluscevic United States	6	437 0.9×	536 1.5×	104 0.5×	41 0.3×	65 0.6×	11	1.1k
Masafumi Takata Japan	12	226 0.5×	760 2.1×	131 0.7×	116 0.9×	29 0.3×	19	1.1k
Valentina Sala Italy	15	100 0.2×	448 1.2×	82 0.4×	44 0.3×	31 0.3×	24	886
Costanza Lamperti Italy	15	144 0.3×	924 2.5×	88 0.4×	107 0.8×	68 0.6×	23	1.2k
Soumi Kundu United States	17	81 0.2×	350 1.0×	44 0.2×	161 1.2×	148 1.3×	32	803

Countries citing papers authored by Yohta Shimada

Since Specialization

Citations

This map shows the geographic impact of Yohta Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yohta Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yohta Shimada more than expected).

Fields of papers citing papers by Yohta Shimada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yohta Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yohta Shimada. The network helps show where Yohta Shimada may publish in the future.

Co-authorship network of co-authors of Yohta Shimada

This figure shows the co-authorship network connecting the top 25 collaborators of Yohta Shimada. A scholar is included among the top collaborators of Yohta Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yohta Shimada. Yohta Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Matsushima, S., Yohta Shimada, Masafumi Kinoshita, et al.. (2025). Adeno-associated virus expressing a blood-brain barrier–penetrating enzyme improves GM1 gangliosidosis in a preclinical model. Journal of Clinical Investigation. 135(12).

Shimada, Yohta, et al.. (2024). Usefulness of antibody-drug conjugate as preconditioning for hematopoietic stem cell-targeted gene therapy in wild-type and Fabry disease mouse models. Molecular Genetics and Metabolism. 142(3). 108494–108494. 1 indexed citations

Taniai, Tomohiko, Yoshihiro Shirai, Yohta Shimada, et al.. (2021). Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells. Cancer Science. 112(11). 4570–4579. 10 indexed citations

Shirai, Yoshihiro, Tadashi Uwagawa, Hiroaki Shiba, et al.. (2017). Recombinant thrombomodulin suppresses tumor growth of pancreatic cancer by blocking thrombin-induced PAR1 and NF-κB activation. Surgery. 161(6). 1675–1682. 23 indexed citations

Higuchi, Takashi, Yohta Shimada, Hiroshi Kobayashi, et al.. (2016). Non-myeloablative preconditioning with ACK2 (anti-c-kit antibody) is efficient in bone marrow transplantation for murine models of mucopolysaccharidosis type II. Molecular Genetics and Metabolism. 119(3). 232–238. 14 indexed citations

Inoue, Kimiko, Saburo Sakoda, Tsuyoshi Matsumura, et al.. (2016). Screening for late‐onset Pompe disease in undiagnosed myopathies. Neurology and Clinical Neuroscience. 5(2). 60–64.

Sato, Yohei, Hiroshi Kobayashi, Takashi Higuchi, et al.. (2016). TFEB overexpression promotes glycogen clearance of Pompe disease iPSC-derived skeletal muscle. Molecular Therapy — Methods & Clinical Development. 3. 16054–16054. 35 indexed citations

Sato, Yohei, Hiroshi Kobayashi, Yohta Shimada, et al.. (2015). Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient. Molecular Therapy — Methods & Clinical Development. 2. 15023–15023. 37 indexed citations

Yamanaka, Shuichiro, Shinya Yokote, Akifumi Yamada, et al.. (2014). Adipose Tissue-Derived Mesenchymal Stem Cells in Long-Term Dialysis Patients Display Downregulation of PCAF Expression and Poor Angiogenesis Activation. PLoS ONE. 9(7). e102311–e102311. 31 indexed citations

10.

Higuchi, Takashi, Yohta Shimada, Hiroshi Kobayashi, et al.. (2013). Morphological features of iPS cells generated from Fabry disease skin fibroblasts using Sendai virus vector (SeVdp). Molecular Genetics and Metabolism. 109(4). 386–389. 45 indexed citations

11.

Higuchi, Takashi, Hiromi Shimizu, Takahiro Fukuda, et al.. (2012). Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II. Molecular Genetics and Metabolism. 107(1-2). 122–128. 42 indexed citations

12.

Kobayashi, Hiroshi, Yohta Shimada, Yoshikatsu Eto, et al.. (2011). Minimum requirement of donor cells to reduce the glycolipid storage following bone marrow transplantation in a murine model of Fabry disease. The Journal of Gene Medicine. 13(5). 262–268. 8 indexed citations

13.

Shimada, Yohta, Hiroshi Kobayashi, Takashi Higuchi, et al.. (2011). Proteasome inhibitors improve the function of mutant lysosomal α-glucosidase in fibroblasts from Pompe disease patient carrying c.546G>T mutation. Biochemical and Biophysical Research Communications. 415(2). 274–278. 18 indexed citations

14.

Shimada, Yohta, Hiroshi Kobayashi, Katsuhiko Aoki, et al.. (2011). Endoplasmic reticulum stress induces autophagy through activation of p38 MAPK in fibroblasts from Pompe disease patients carrying c.546G>T mutation. Molecular Genetics and Metabolism. 104(4). 566–573. 40 indexed citations

15.

Kobayashi, Hiroshi, Yohta Shimada, Masahiro Ikegami, et al.. (2010). Prognostic factors for the late onset Pompe disease with enzyme replacement therapy: From our experience of 4 cases including an autopsy case. Molecular Genetics and Metabolism. 100(1). 14–19. 42 indexed citations

16.

Kobayashi, Hiroshi, Junko Takahashi‐Fujigasaki, Takahiro Fukuda, et al.. (2010). Pathology of the first autopsy case diagnosed as mucolipidosis type III α/β suggesting autophagic dysfunction. Molecular Genetics and Metabolism. 102(2). 170–175. 16 indexed citations

17.

Shimada, Yohta, Takahiro Fukuda, Katsuhiko Aoki, et al.. (2008). A protocol for immunoaffinity separation of the accumulated ubiquitin–protein conjugates solubilized with sodium dodecyl sulfate. Analytical Biochemistry. 377(1). 77–82. 18 indexed citations

18.

Minami, Jiro, Koji Takada, Katsuhiko Aoki, et al.. (2006). Purification and characterization of C-terminal truncated forms of histone H2A in monocytic THP-1 cells. The International Journal of Biochemistry & Cell Biology. 39(1). 171–180. 9 indexed citations

19.

Yasui, Hiroyuki, Kuniaki Shirao, Nobuyuki Yamamoto, et al.. (2005). A phase I study of the chimeric monoclonal anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a single agent in subjects from Japan with advanced solid tumors: Safety, pharmacokinetics (PK). Journal of Clinical Oncology. 23(16_suppl). 3209–3209. 3 indexed citations

20.

Fukuda, Taeko, et al.. (1996). Quality Evaluation on Paeoniae Radix. I. Quantitative Analysis of Monoterpene Glycosides Constituents of Paeoniae Radix by Means of High Performance Liquid Chromatography. Comparative Characterization of the External Figures, Processing Method and the Cultivated Areas. YAKUGAKU ZASSHI. 116(2). 138–147. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact